11-hydroxyandrostenedione has been researched along with pregnenolone sulfate in 1 studies
| Studies (11-hydroxyandrostenedione) | Trials (11-hydroxyandrostenedione) | Recent Studies (post-2010) (11-hydroxyandrostenedione) | Studies (pregnenolone sulfate) | Trials (pregnenolone sulfate) | Recent Studies (post-2010) (pregnenolone sulfate) |
|---|---|---|---|---|---|
| 83 | 2 | 16 | 382 | 2 | 99 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auchus, RJ; Avila, NA; Elman, MS; Mallappa, A; Marko, J; Merke, DP; Rao, H; Tsodikov, A; Turcu, AF | 1 |
1 other study(ies) available for 11-hydroxyandrostenedione and pregnenolone sulfate
| Article | Year |
|---|---|
11-Oxygenated Androgens Are Biomarkers of Adrenal Volume and Testicular Adrenal Rest Tumors in 21-Hydroxylase Deficiency.
Topics: 17-alpha-Hydroxypregnenolone; Adolescent; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenal Rest Tumor; Adult; Age Determination by Skeleton; Aged; Androgens; Androstenedione; Androstenes; Child; Child, Preschool; Cortodoxone; Cross-Sectional Studies; Female; Hirsutism; Humans; Hydroxytestosterones; Male; Menstruation Disturbances; Middle Aged; Organ Size; Pregnenolone; Testicular Neoplasms; Testosterone; Young Adult | 2017 |